Coding

Part:BBa_K4739011

Designed by: Huaiyuan Ma   Group: iGEM23_SUSTech-Shenzhen   (2023-10-11)


KLA, a pro-apoptotic experimental peptide drug in cancer threapy

KLA is an experimental peptide drug that can disrupt the mitochondrial membrane and induce cell apoptosis. Its therapeutic ability is limited by its membrane permeability. We adopt this drug in our project to tackle the problem and provide a viable solution to colon cancer.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 15
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


[edit]
Categories
Parameters
None